Search clinical trials for: Aromatase inhibitor
Total 64275 results
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
Cairo UniversityCompleted
-
Centre for Endocrinology and Reproductive Medicine...Completed
-
Fudan UniversityWithdrawnCarcinoma Breast Stage IV
-
The University of Hong KongCompleted
-
University of VirginiaNational Cancer Institute (NCI)CompletedBreast Cancer | OsteoporosisUnited States
-
Novartis PharmaceuticalsCompletedBreast NeoplasmUnited States, Germany, Spain, United Kingdom, France, Austria, Russian Federation, Italy, Canada, Belgium
-
Dr. Reddy's Laboratories LimitedCompleted
-
St George Hospital, AustraliaAstraZenecaUnknown
-
Weill Medical College of Cornell UniversityCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastSpain, Italy
-
Institut Català d'OncologiaUnknown
-
Onconova Therapeutics, Inc.RecruitingEndometrioid Endometrial CancerUnited States
-
Assiut UniversityNot yet recruiting
-
Queen Mary Hospital, Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsRecruiting
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Arvinas Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain, Germany, Georgia
-
Rovi Pharmaceuticals LaboratoriesActive, not recruiting
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated
-
Calithera Biosciences, IncCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Estrogen Receptor Positive | PostmenopausalUnited States
-
The First Affiliated Hospital of Guangzhou Medical...Karolinska Institutet; The University of Hong Kong; Xuzhou Maternity and Child... and other collaboratorsCompleted
-
UNICANCERCompleted
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
SanofiCompletedBreast CancerUnited States, France, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Mount Sinai Hospital, CanadaCompletedBreast CancerCanada
-
Hospital Affiliated to Military Medical Science...UnknownMetastatic Breast CancerChina
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
Mansoura UniversityCompleted
-
Mansoura UniversityCompletedPolycystic Ovary SyndromeEgypt
-
Eunice Kennedy Shriver National Institute of Child...WithdrawnMetabolic Syndrome
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, China, Spain, Hungary, Japan, Australia, Brazil, Italy, Slovakia, Switzerland
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast CancerUnited States
-
Boston Children's HospitalRecruiting
-
M.D. Anderson Cancer CenterNovartisActive, not recruiting
-
Sun Yat-sen UniversityCompleted
-
Yantai Yuhuangding HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruitingAdvanced Breast CancerChina
-
Shengjing HospitalRecruiting
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompletedBreast CancerCanada, United States